International Assets Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
International Assets Investment Management's IBB Position: Q2 2026 in Review
International Assets Investment Management increased its iShares Biotechnology ETF (IBB) stake by 6.3% in Q2 2026, buying an estimated $21K and bringing the position to 2,074 shares worth $394K. The position accounts for 0.02% of the portfolio, ranked #577.
International Assets Investment Management first reported a position in IBB in Q1 2020 and has held it in 15 quarters since. The position peaked at $1.69M in Q2 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- International Assets Investment Management held 2,074 shares of iShares Biotechnology ETF worth $394K as of Q2 2026.
- International Assets Investment Management bought 122 iShares Biotechnology ETF shares in Q2 2026, an estimated $21K.
- iShares Biotechnology ETF made up 0.02% of International Assets Investment Management's portfolio in Q2 2026, its #577 holding.
- International Assets Investment Management first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 15 quarters since.
- International Assets Investment Management's iShares Biotechnology ETF position peaked at $1.69M in Q2 2020.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.